Source: International Congress 2019 – Rare and ultra-rare diseases and the lungs: updates and new perspectives
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Mayer (Philadelphia, United States of America), M. Leinonen (Pratteln, Switzerland), S. Hasham (Pratteln, Switzerland), G. Buyse On Behalf Of The Syros Investigators (Leuven, Belgium). Long term efficacy: Idebenone reduces the rate of both inspiratory and expiratory functional loss in Duchenne muscular dystrophy (DMD). 5331

Member's Comments

No comment yet.

Related content which might interest you:

• The updated treatment algorithm in PAH
• Diagnosis and treatment of chronic pulmonary embolism
• Treatment of acute pulmonary embolism